Singapore-based Farrer Park Hospital introduces AI colorectal screening service
14 Jun 2022
Collaborate
Farrer Park Hospital, a private tertiary care provider in Singapore, has started offering its latest AI-assisted colorectal screening service to improve its detection, classification, screening and monitoring of colorectal polyps and cancer.
The hospital is using an AI screening tool which automatically alerts doctors in real-time of suspected lesions and polyps.
The service was tried out between March and April when over 360 colonoscopies were done. It was officially introduced as a new hospital offering in May.
WHY IT MATTERS
Colorectal cancer is the leading cause of cancer deaths in Singapore,
affecting around 1,800 people each year
. FPH introduced its latest AI screening service to enable "more accurate detection of polyps," according to a press release.
Dr Desmond Wai, a consultant gastroenterologist at FPH, said the technology helps reduce false negative results and avoids the risk of missing polyps by clearly highlighting them. "This improves the accuracy of the scopes conducted which are essential in a patient's health journey," he said.
The use of AI is particularly useful for identifying flat and sessile polyps, which are often missed, noted Dr Chew Min Hoe, a senior consultant and colorectal surgeon at FPH.
THE LARGER TREND
In recent years, FPH has been turning to AI to improve its health services. In September last year, it reported employing an
AI-enabled MRI screening tool for dementia
to enhance dementia diagnosis.
In November, the company partnered with Medtronic to launch its AI-assisted early screening service for cardiac diseases. The programme uses a digital auscultation device with ECG and AI from Medtronic which identifies missing sounds in patients' hearts that would otherwise go unnoticed.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.